大鼠脂肪间充质干细胞体外转染为胰岛素分泌细胞的实验研究

Experimental study of adipose derived mesenchymal stem cells in rats transfected into the insulin secreting cells in vitro

  • 摘要: 目的 探讨脂肪间充质干细胞(ADMSCs)体外转染成为胰岛素分泌细胞的可能性及其在不同浓度葡萄糖环境下的胰岛素分泌情况。方法 以未转染的ADMSCs作为对照组,含有PcDNA3.1的ADMSCs作为空载体组,含有PcDNA3.1hINS的ADMSCs作为重组载体组,转染后再将重组载体组根据培养时间不同分为1、6、12、18 d组,并将重组载体18 d组根据葡萄糖浓度的不同分为高糖组和低糖组。RTPCR扩增人胰岛素基因,并构建含有人胰岛素基因的真核表达重组载体PcDNA3.1hINS。经离心消化法获得ADMSCs,并通过流式细胞仪检测。瞬时转染,RTPCR测各组胰岛素DNA的转录,ELISA法检测各组胰岛素分泌量,并对重组载体18 d组行葡萄糖刺激实验,计量资料以±s表示,多组间的比较采用方差分析,两组比较采用t检验。结果 流式细胞仪检测ADMSCs表面抗原:CD44、CD90、CD106表达阳性,CD34、CD45、CD11b表达阴性。RTPCR法检测重组载体组有胰岛素DNA转录,对照组和空载体组均无转录。ELISA法检测重组载体1、6、12、18 d组胰岛素分泌量分别为(4.7±0.8)mIU/L、(8.8±0.5)mIU/L、(8.9±0.8)mIU/L、(8.6±0.6)mIU/L,与对照组的(1.3±0.6)mIU/L和空载体组的(1.7±0.8)mIU/L分别比较,差异均有统计学意义(t=10.09,32.64,22.20,55.53;9.23,27.56,19.43,51.25,P<0.05);重组载体1 d组与6、12、18 d组的胰岛素分泌量分别比较,差异有统计学意义(t=12.77,12.26,13.93,P<0.05);而6、12、18 d组间的胰岛素分泌量比较,差异无统计学意义(F=45.67,P>0.05)。高糖组和低糖组胰岛素分泌量比较,差异有统计学意义(t=2.03,P<0.05)。葡萄糖刺激实验阴性。

     

    Abstract: Objective To investigate the possibility of transfection of adiposederived mesenchymal stem cells (ADMSCs) into the insulinsecreting cells in vitro, and assay the secretion of insulin of ADMSCs in high and low glucose environment.Methods The ADMSCs that untransfected were in the control group, the ADMSCs that contained PcDNA3.1 were in the vacant vector group, and the ADMSCs that contained PcDNA3.1hINS were in the recombinant vector group. After transfection, the recombinant vector group were subdivided into the 1, 6, 12, 18 days groups. According to the concentrations of glucose, the recombinant vector 18 days group were divided into the high glucose group and low glucose group. Human insulin gene was amplified by RTPCR, and the eukaryotic expression recombinant vector PcDNA3.1hINS that contained the human insulin gene was constructed. The ADMSCs were obtained by digestion and centrifugation, and then underwent flow cytometry for identification. The transcription of insulin DNA was assayed by RTPCR, and the levels of insulin were assayed by ELISA. Glucose test was done in the recombinant vector 18 days group. The measurement data was shown in the format of ±s, the measurement data in multiple groups were compared by randomized analysis of variance, and the comparison among groups was performed by the t test. Results The expressions of CD44, CD90, CD106 were positive, and the expressions of CD34, CD45 and CD11b were negative. No insulin DNA transcription was detected in the control group and vacant vector group. The levels of insulin secreted were (4.7±0.8)mIU/L, (8.8±0.5)mIU/L, (8.9±0.8)mIU/L, (8.6±0.6)mIU/L in the recombinant vector 1, 6, 12, 18 days group, which were significantly higher than (1.3±0.6)mIU/L in the control group and (1.7±0.8)mIU/L in the vacant vector group (t=10.09, 32.64, 22.20, 55.53; 9.23, 27.56, 19.43, 51.25, P<0.05). There were significant differences in the levels of insulin secreted between the recombinant vector 1 day group and the recombinant vector 6, 12, 18 days groups (t=12.77, 12.26, 13.93, P<0.05). There were no significant difference in the levels of insulin secreted between the recombinant vector 6, 12, 18 days groups (F=45.67, P>0.05). There was a significant difference in the level of insulin secreted between the high glucose group and the low glucose group (t=2.03, P<0.05). The result of the glucose stimulation test was negative. Conclusion The ADMSCs are transfected into insulinsecreting cells in vitro successfully, and the secretion of insulin is stable. Although the secretion of insulin can′t change in line with the concentration of glucose, it is a new seed cell for the treatment of diabetes with stem cells.

     

/

返回文章
返回